Also known as RDEA 594, Zurampic®, RDEA-594, RDEA594
Lesinurad (brand name Zurampic) is a urate transporter inhibitor for treating high blood uric acid levels associated with gout. It is recommended only as an adjuvant with either allopurinol or febuxostat when these medications are not sufficient.
via PubMed
~5 min read
{{Infobox drug | drug_name = | type = | IUPAC_name = 2-{[5-Bromo-4-(4-cyclopropyl-1-naphthyl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid | image = Lesinurad.svg | image_class = skin-invert-image | width = 180 | image2 = Lesinurad ball-and-stick model.png | image_class2 = bg-transparent
| pronounce = | tradename = Zurampic | Drugs.com = | MedlinePlus = a616015 | DailyMedID = Lesinurad | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_US = | pregnancy_category = | licence_EU = yes | legal_AU = S4 | legal_AU_comment = | legal_CA = | legal_DE = | legal_NZ = | legal_UK = | legal_US = Rx-only | legal_UN = | legal_status = | routes_of_administration = Oral (tablets)
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).